BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

AnorMED

About AnorMED:

AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hemotology, HIV and oncology.

AnorMED's core strength involves the application of chemistry, biochemistry and biology to the discover and development of small molecule therapeutics with distinct pharmocological properties and therapeutic potential.

 

Pipeline Chart for AnorMED

 

AMD3100, a stem cell mobilizer

AMD070 --HIV Inhibitor is a small molecule drug candidate that belongs to a new investigational class of anti-HIV drugs known as entry inhibitors. AMD070 targets the CXCR4 chemokine receptor and prevents HIV from entering and infecting healthy cells.



More on Anor
Med:

Home Page



Basic Chart for AnorMed



 
Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com